The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors - PubMed (original) (raw)
. 2006 Jul 7;281(27):18626-37.
doi: 10.1074/jbc.M512308200. Epub 2006 May 3.
Ilse Van Aelst, Vibeke Hvidberg, Helene Piccard, Pierre Fiten, Christian Jacobsen, Soren K Moestrup, Simon Fry, Louise Royle, Mark R Wormald, Russell Wallis, Pauline M Rudd, Raymond A Dwek, Ghislain Opdenakker
Affiliations
- PMID: 16672230
- DOI: 10.1074/jbc.M512308200
Free article
The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors
Philippe E Van den Steen et al. J Biol Chem. 2006.
Free article
Abstract
Gelatinase B/matrix metalloproteinase-9 (MMP-9), a key regulator and effector of immunity, contains a C-terminal hemopexin domain preceded by a unique linker sequence of approximately 64 amino acid residues. This linker sequence is demonstrated to be an extensively O-glycosylated (OG) domain with a compact three-dimensional structure. The OG and hemopexin domains have no influence on the cleavage efficiency of MMP-9 substrates. In contrast, the hemopexin domain contains a binding site for the cargo receptor low density lipoprotein receptor-related protein-1 (LRP-1). Furthermore, megalin/LRP-2 is identified as a new functional receptor for the hemopexin domain of MMP-9, able to mediate the endocytosis and catabolism of the enzyme. The OG domain is required to correctly orient the hemopexin domain for inhibition by TIMP-1 and internalization by LRP-1 and megalin. Therefore, the OG and hemopexin domains down-regulate the bioavailability of active MMP-9 and the interactions with the cargo receptors are proposed to be the original function of hemopexin domains in MMPs.
Similar articles
- Kinetic analysis of the binding of hemopexin-like domain of gelatinase B cloned and expressed in Pichia pastoris to tissue inhibitor of metalloproteinases-1.
Stute J, Pourmotabbed T, Tschesche H. Stute J, et al. J Protein Chem. 2003 Aug;22(6):509-14. doi: 10.1023/b:jopc.0000005499.51466.50. J Protein Chem. 2003. PMID: 14703983 - Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Geurts N, Martens E, Van Aelst I, Proost P, Opdenakker G, Van den Steen PE. Geurts N, et al. Biochemistry. 2008 Feb 26;47(8):2689-99. doi: 10.1021/bi702260q. Epub 2008 Feb 1. Biochemistry. 2008. PMID: 18237197 - The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist.
Roeb E, Schleinkofer K, Kernebeck T, Pötsch S, Jansen B, Behrmann I, Matern S, Grötzinger J. Roeb E, et al. J Biol Chem. 2002 Dec 27;277(52):50326-32. doi: 10.1074/jbc.M207446200. Epub 2002 Oct 15. J Biol Chem. 2002. PMID: 12384502 - Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Vandooren J, Van den Steen PE, Opdenakker G. Vandooren J, et al. Crit Rev Biochem Mol Biol. 2013 May-Jun;48(3):222-72. doi: 10.3109/10409238.2013.770819. Epub 2013 Apr 2. Crit Rev Biochem Mol Biol. 2013. PMID: 23547785 Review. - Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins.
Piccard H, Van den Steen PE, Opdenakker G. Piccard H, et al. J Leukoc Biol. 2007 Apr;81(4):870-92. doi: 10.1189/jlb.1006629. Epub 2006 Dec 21. J Leukoc Biol. 2007. PMID: 17185359 Review.
Cited by
- Protection of stromal cell-derived factor-1 SDF-1/CXCL12 against proteases yields improved skin wound healing.
Pereira RVS, EzEldeen M, Ugarte-Berzal E, Vandooren J, Martens E, Gouwy M, Ganseman E, Van Damme J, Matthys P, Vranckx JJ, Proost P, Opdenakker G. Pereira RVS, et al. Front Immunol. 2024 Aug 2;15:1359497. doi: 10.3389/fimmu.2024.1359497. eCollection 2024. Front Immunol. 2024. PMID: 39156898 Free PMC article. - Proteolytic Vesicles Derived from Salmonella enterica Serovar Typhimurium-Infected Macrophages: Enhancing MMP-9-Mediated Invasion and EV Accumulation.
Nudelman A, Shenoy A, Allouche-Arnon H, Fisler M, Rosenhek-Goldian I, Dayan L, Abou Karam P, Porat Z, Solomonov I, Regev-Rudzki N, Bar-Shir A, Sagi I. Nudelman A, et al. Biomedicines. 2024 Feb 15;12(2):434. doi: 10.3390/biomedicines12020434. Biomedicines. 2024. PMID: 38398037 Free PMC article. - Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage.
Visser N, Herreman LCM, Vandooren J, Pereira RVS, Opdenakker G, Spelbrink REJ, Wilbrink MH, Bremer E, Gosens R, Nawijn MC, van der Ende-Metselaar HH, Smit JM, Laus MC, Laman JD. Visser N, et al. J Mol Med (Berl). 2024 Apr;102(4):521-536. doi: 10.1007/s00109-024-02423-x. Epub 2024 Feb 21. J Mol Med (Berl). 2024. PMID: 38381158 Free PMC article. - Truncated O-glycosylation in metastatic triple-negative breast cancer reveals a gene expression signature associated with extracellular matrix and proteolysis.
Festari MF, Jara E, Costa M, Iriarte A, Freire T. Festari MF, et al. Sci Rep. 2024 Jan 20;14(1):1809. doi: 10.1038/s41598-024-52204-2. Sci Rep. 2024. PMID: 38245559 Free PMC article. - Correlation of TIMP1-MMP2/MMP9 Gene Expression Axis Changes with Treatment Efficacy and Survival of NSCLC Patients.
Pietrzak J, Wosiak A, Szmajda-Krygier D, Świechowski R, Łochowski M, Pązik M, Balcerczak E. Pietrzak J, et al. Biomedicines. 2023 Jun 21;11(7):1777. doi: 10.3390/biomedicines11071777. Biomedicines. 2023. PMID: 37509417 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous